Finance

Beta
Lists
COYA:NASDAQ
Coya Therapeutics Inc
$4.64
-1.90%
(-0.090) 1D
$4.65
+0.22% (+0.010)
Pre-market
Closed: Jun 3, 4:00:01 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for COYA...
Open
$4.72
High
$4.74
Low
$4.40
Mkt. cap
108.84M
Avg. vol.
162.93K
Volume
0.00
52-wk high
$7.75
52-wk low
$3.71
EPS
-$1.15
Beta
0.62
Shares outstanding
23.46M
No. of employees
8
Open
$4.72
High
$4.74
Low
$4.40
Mkt. cap
108.84M
Avg. vol.
162.93K
Volume
0.00
52-wk high
$7.75
52-wk low
$3.71
EPS
-$1.15
Beta
0.62
Shares outstanding
23.46M
No. of employees
8
Analyst outlook
Analyst Ratings
Based on 4 analysts giving stock ratings to COYA in the past 3 months
Strong Buy
Buy
4
Hold
0
Sell
0
12 month forecast
Based on 4 Wall Street analysts offering 12 month price targets for COYA in the last 3 months.
Highest
Current $4.64
$18.00 (+287.93%)
Average
$16.25 (+250.22%)
Lowest
$14.00 (+201.72%)
News stories
From sources across the web
About Coya Therapeutics Inc
CEO-
Employees8
Founded2020
HeadquartersHouston, Texas, United States
SectorBiotechnology
Websitecoyatherapeutics.com
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
163.62K
3.56M
3.96M
251.15K
Cost of goods sold
3.66M
2.92M
4.94M
4.10M
Cost of revenue
3.66M
2.92M
4.94M
4.10M
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
2.91M
2.56M
3.27M
3.78M
Operating expense
2.92M
2.56M
3.28M
3.78M
Total operating expenses
6.58M
5.48M
8.22M
7.88M
Operating income
-6.41M
-1.92M
-4.26M
-7.63M
Other non operating income
-
-
-
-
EBT including unusual items
-6.09M
-2.12M
-5.71M
-7.21M
EBT excluding unusual items
-6.09M
-1.60M
-3.93M
-7.20M
Income tax expense
-
-
3.09K
-
Effective tax rate
-
-
-0.05%
-
Other operating expenses
-
-
-
-
Net income
-6.09M
-2.12M
-5.71M
-7.21M
Net profit margin
-3,725.17%
-59.36%
-144.16%
-2,869.63%
Earnings per share
-0.36
-0.13
-0.34
-0.32
Interest and investment income
319.54K
317.07K
325.44K
433.23K
Interest expense
-
-
-
-
Net interest expenses
319.54K
317.07K
325.44K
433.23K
Depreciation and amortization charges
6.84K
6.84K
6.84K
2.81K
EBITDA
-6.41M
-1.91M
-4.25M
-7.63M
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer